What is this medicine used for?
FDA-approved uses
- Postherpetic neuralgia — Adults. Pain after shingles; not an approval for every pain condition.Neurontin immediate-release capsules; Neurontin immediate-release tablets; Neurontin oral solution.
- Adjunctive treatment of partial-onset seizures — Adults and children aged 3 years or older. Added to seizure treatment; pediatric dosing is age- and weight-specific.Neurontin immediate-release capsules; Neurontin immediate-release tablets; Neurontin oral solution.
Other uses (off-label)
Off-label means a medicine is prescribed for a use, age group or form that is not included in its FDA approval.
- Selected alcohol-use-disorder and mild-to-moderate withdrawal circumstances — Adults. VA/DoD recommendations are conditional and weak; not a home detoxification regimen.Neurontin immediate-release capsules; Neurontin immediate-release tablets; Neurontin oral solution.
Read more: Alcohol Use Disorder.
What should I expect?
Benefit and dose adjustment depend on the reason for treatment. Drowsiness or unsteadiness can appear early, and pain or other symptoms should be reviewed over time rather than judged from one dose.
For an off-label use, agree on the target and a review point. Gabapentin should not be assumed to be an effective general anxiety medicine or bipolar mood stabilizer.
How do I take it safely?
The covered Neurontin immediate-release products can be taken with or without food; follow the prescribed spacing. Liquid needs a proper measuring device. Take gabapentin at least two hours after an aluminum/magnesium antacid. Do not substitute Gralise or Horizant instructions.
Kidney function determines dose suitability. Avoid alcohol and have opioids, sleep medicines and other sedatives reviewed because breathing can slow dangerously. Do not drive until you know how alert and steady you are.
Monitor benefit, mood, swelling, sedation and misuse or withdrawal concerns. Discuss pregnancy and breastfeeding. Pediatric seizure use has specific age rules; that approval does not establish pediatric psychiatric benefit.
Arrange a gradual reduction; the label specifies at least one week, and some people need longer. Withdrawal and increased seizures can follow rapid stopping. Do not take two doses together; ask about the exact missed-dose plan or restarting after several missed doses.
Do not use this product after a known allergy to its active medicine or ingredients; tell the pharmacist about previous medication reactions.
What side effects should I know about?
- Dizziness, sleepiness, unsteadiness, fatigue, and peripheral swelling.
- Children may develop changes in mood, behavior or school performance, including irritability, hostility, restlessness or trouble concentrating. Tell the prescriber about new changes instead of assuming they are part of the original condition.
Tell your prescriber about effects that are persistent, troublesome, or interfere with daily life.
Looking for more detailed information?
The official medicine information lists more side effects, safety advice and product instructions.
- View FDA Prescribing Information (PDF) (opens in a new tab)NEURONTIN- gabapentin capsule
Which warning signs need help?
- Slow or difficult breathing, profound sleepiness, blue or gray lips or inability to wake is an emergency, especially with opioids or other sedatives. A prolonged seizure, collapse or suspected overdose also needs emergency care.
- Fever, swollen glands, rash or facial swelling can indicate a serious multiorgan reaction, sometimes before a rash appears. Obtain immediate medical assessment; airway swelling or breathing difficulty requires emergency care.
- Contact the prescriber promptly for new suicidal thoughts, worsening depression or unusual behavior. Use emergency care if there is immediate danger or the person cannot stay safe. Withdrawal and worsening seizures can occur after rapid reduction or stopping. Suicidal thoughts or behavior have also been reported after stopping; continue watching for mood or behavior changes during and after a prescriber-guided reduction.
What else should I know to stay safe?
- Kidney function affects dosing. Review lung disease, falls and all opioids or sedatives; avoid alcohol and driving when alertness or coordination is affected. Do not use after product allergy.
- Monitor benefit, mood, swelling and signs of misuse or dependence. Discuss pregnancy and breastfeeding; pediatric seizure approval does not establish pediatric psychiatric benefit.
- Arrange a gradual reduction with the prescriber. The label specifies at least one week, but some people need longer; do not use that minimum as a personal taper plan. Different gabapentin-related products are not interchangeable.
Urgent help and crisis support · Emergency & Crisis Resources (US)
What can help day to day?
- Despite its name and chemical relationship to GABA, gabapentin does not simply replace that brain messenger.
- Neurontin, Gralise and Horizant have different delivery or ingredients and instructions. A similar name is not a safe basis for substitution.
How does it work?
Gabapentin attaches to part of certain calcium channels in nerve cells, changing how cells release chemical messages. How this produces all of its clinical benefits is not fully understood. Despite its name, it does not act directly like the brain messenger GABA.
How was this medicine developed?
Neurontin capsules were approved in 1993, followed by an adult role in pain after shingles. Later research explored other conditions, while FDA safety updates emphasized breathing suppression and the risks of abrupt discontinuation.
How do I say the name?
Gabapentin: GA-ba-pen-tin. Capital letters show the stressed syllable.
Medicine forms and official information
Match the full name, release type and route on your prescription. Different formulations need their own prescribing instructions; do not switch or substitute them yourself.
Choose a formulation
- Neurontin immediate-release capsules
- Neurontin immediate-release tablets
- Neurontin oral solution
- Gralise separate oral release formulation
Neurontin immediate-release capsules
100, 300, 400 mg capsules; oral immediate-release scope.
Neurontin immediate-release tablets
600 and 800 mg scored tablets; product-specific half-tablet instructions.
Neurontin oral solution
250 mg per 5 mL; oral solution requires refrigeration.
Gralise separate oral release formulation
Separate pharmacokinetic profile and schedule; not interchangeable.
Sources and References
Sources support the U.S. products described here. Product instructions can differ; use the information supplied with your own medicine.
- VA/DoD substance-use guideline, 2021: recommendations 6 and 14
- Neurontin capsules, tablets and oral solution: current prescribing information
- Neurontin capsules: FDA approval history
- Gabapentin: MedlinePlus Drug Information
- Neurontin: FDA prescribing information, April 2025
- Neurontin: Package Insert / Prescribing Information / MOA
- DailyMed - GABAPENTIN tablet
- Gabapentinoids: FDA warning about serious breathing problems
- NICE bipolar guideline: recommendation 1.10.4
Scope: England; nation-specific implementation must be checked.
- Pande and colleagues: gabapentin trial for social phobia, 1999
- Gralise: separate product labeling and non-substitution warning
- Horizant (gabapentin enacarbil): separate prodrug labeling
- Lyrica: current prescribing information
- Gabapentin: verified neutral parent, PubChem CID 3446
- ISMP List of Confused Drug Names
- High-Alert Medications in Long-Term Care (LTC) Settings
- ISMP List of High-Alert Medications in Community/Ambulatory Care Settings
Giving medicine safely to children: family guide (PDF, 3 pages)

